Search research articles
Contact Us
Filters
Showing results (151-160 of 198) with videos related to
Page
of 20
Sort By:
Cancer Causes & Control : CCC
|
April 30, 2016
Insulin/IGF and sex hormone axes in human endometrium and associations with endometrial cancer risk factors
Melissa A Merritt, Howard D Strickler, Mark H Einstein, et al.
Gynecologic Oncology
|
January 31, 2014
A phase II trial of oxaliplatin, docetaxel, and bevacizumab as first-line therapy of advanced cancer of the ovary, peritoneum, and fallopian tube
Thomas J Herzog, Bradley J Monk, Peter G Rose, et al.
The Journal of Infectious Diseases
|
September 4, 2010
Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in HIV-1-infected men
Timothy Wilkin, Jeannette Y Lee, Shelly Y Lensing, et al.
Journal of Psychiatric Research
|
May 11, 2024
Deep brain stimulation of the amygdala for treatment-resistant combat post-traumatic stress disorder: Long-term results
Ralph J Koek, Josue Avecillas-Chasin, Scott E Krahl, et al.
Journal of Lower Genital Tract Disease
|
August 1, 2020
Response to Letter to the Editor Regarding: 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors
Rebecca B Perkins, Richard L Guido, Philip E Castle, et al.
Gynecologic Oncology
|
November 26, 2009
Paclitaxel plus oxaliplatin for recurrent or metastatic cervical cancer: a New York Cancer Consortium Study
Dennis Yi-Shin Kuo, Stephanie V Blank, Paul J Christos, et al.
Human Vaccines
|
November 4, 2011
Comparison of the immunogenicity of the human papillomavirus (HPV)-16/18 vaccine and the HPV-6/11/16/18 vaccine for oncogenic non-vaccine types HPV-31 and HPV-45 in healthy women aged 18-45 years
Mark H Einstein, Mira Baron, Myron J Levin, et al.
Journal of Lower Genital Tract Disease
|
April 4, 2020
2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors
Rebecca B Perkins, Richard S Guido, Philip E Castle, et al.
Journal of Lower Genital Tract Disease
|
September 28, 2017
ASCCP Colposcopy Standards: Colposcopy Quality Improvement Recommendations for the United States
Edward J Mayeaux, Akiva P Novetsky, David Chelmow, et al.
Journal of Lower Genital Tract Disease
|
September 20, 2021
Erratum: 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors
Rebecca B Perkins, Richard S Guido, Philip E Castle, et al.
Page
of 20
Search research articles
Search
Showing results (151-160 of 198) with videos related to
Sort By:
Page
of 20
Cancer Causes & Control : CCC
|
April 30, 2016
Insulin/IGF and sex hormone axes in human endometrium and associations with endometrial cancer risk factors
Melissa A Merritt, Howard D Strickler, Mark H Einstein, et al.
Gynecologic Oncology
|
January 31, 2014
A phase II trial of oxaliplatin, docetaxel, and bevacizumab as first-line therapy of advanced cancer of the ovary, peritoneum, and fallopian tube
Thomas J Herzog, Bradley J Monk, Peter G Rose, et al.
The Journal of Infectious Diseases
|
September 4, 2010
Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in HIV-1-infected men
Timothy Wilkin, Jeannette Y Lee, Shelly Y Lensing, et al.
Journal of Psychiatric Research
|
May 11, 2024
Deep brain stimulation of the amygdala for treatment-resistant combat post-traumatic stress disorder: Long-term results
Ralph J Koek, Josue Avecillas-Chasin, Scott E Krahl, et al.
Journal of Lower Genital Tract Disease
|
August 1, 2020
Response to Letter to the Editor Regarding: 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors
Rebecca B Perkins, Richard L Guido, Philip E Castle, et al.
Gynecologic Oncology
|
November 26, 2009
Paclitaxel plus oxaliplatin for recurrent or metastatic cervical cancer: a New York Cancer Consortium Study
Dennis Yi-Shin Kuo, Stephanie V Blank, Paul J Christos, et al.
Human Vaccines
|
November 4, 2011
Comparison of the immunogenicity of the human papillomavirus (HPV)-16/18 vaccine and the HPV-6/11/16/18 vaccine for oncogenic non-vaccine types HPV-31 and HPV-45 in healthy women aged 18-45 years
Mark H Einstein, Mira Baron, Myron J Levin, et al.
Journal of Lower Genital Tract Disease
|
April 4, 2020
2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors
Rebecca B Perkins, Richard S Guido, Philip E Castle, et al.
Journal of Lower Genital Tract Disease
|
September 28, 2017
ASCCP Colposcopy Standards: Colposcopy Quality Improvement Recommendations for the United States
Edward J Mayeaux, Akiva P Novetsky, David Chelmow, et al.
Journal of Lower Genital Tract Disease
|
September 20, 2021
Erratum: 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors
Rebecca B Perkins, Richard S Guido, Philip E Castle, et al.
Page
of 20